ADVERTISEMENT

pharma

Opinion: Sexual Dysfunction Matters
Robert Pyke | Aug 19, 2013 | 3 min read
Desire and arousal disorders require the biopharmaceutical industry’s attention.
Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
BPTW: By The Numbers
The Scientist | May 31, 2013 | 1 min read
Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Gold Dust Missing from Pfizer Lab
Jef Akst | Dec 10, 2012 | 1 min read
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
Neurologist Reveals Insider Information
Edyta Zielinska | Nov 26, 2012 | 1 min read
A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
Opinion: Eliminating Meningitis
Rino Rappuoli | Sep 17, 2012 | 3 min read
Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.
Obama Signs FDA Bill
Bob Grant | Jul 11, 2012 | 2 min read
The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.
Opinion: On the Up and Up
Sean E. Harper | Jun 20, 2012 | 2 min read
An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
@Pharma Branching Out
Hayley Dunning | Jun 11, 2012 | 1 min read
More than half of pharmaceutical companies on Twitter use more than one handle.
Avant-Garde Science
Mary Beth Aberlin | Jun 1, 2012 | 3 min read
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Pharma Puts Up Money for Biotech
Jef Akst | Mar 21, 2012 | 2 min read
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
Self-prescribing Patients?
Jef Akst | Mar 13, 2012 | 1 min read
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Opinion: A Big Pharma Biotech Fund
Mark Kessel | Mar 5, 2012 | 4 min read
Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.
Female Frontrunners
Jef Akst | Feb 1, 2012 | 7 min read
How to successfully surmount the challenges women face in becoming biotech industry leaders
Opinion: Celebrities Pushing Drugs?
Howard Brody | Jan 30, 2012 | 4 min read
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
FDA Drafts Pharma Social Media Advice
Tia Ghose | Jan 3, 2012 | 1 min read
The agency releases draft guidelines on unsolicited questions about off-label use, but leaves many questions about social media marketing unanswered.
The Companies that Failed
Edyta Zielinska | Dec 20, 2011 | 3 min read
A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times
Universities Roll-back Pharma’s Fees
Edyta Zielinska | Dec 20, 2011 | 1 min read
Research universities are removing the licensing fees they charged industry companies for working with their scientists.
Pharma Learns from Carmakers
Jef Akst | Dec 14, 2011 | 2 min read
Some Big Pharma companies are turning to the world’s automobile makers for advice on innovation and profitability.
ADVERTISEMENT